SEC Form 4 research
| Issuer | Veraxa Biotech Holding AG |
|---|---|
| Tickers | VRXA |
| Reporting owners | 9 |
| Officers and directors | 4 |
| Last public filing | 2026-10-29 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-29 | 2026-10-28 | Gruninger Marc | P | 9,133 | $1 | Not reported |
| 2026-10-29 | 2026-10-27 | Gruninger Marc | P | 867 | $0.98 | Not reported |
| 2026-10-21 | 2026-10-20 | Ziegler Christoph Samuel | P | 30,000 | $1.09 | Not reported |
| 2026-08-31 | 2026-08-27 | Baumann Oliver Rolf | P | 50,000 | $1.5 | Not reported |
| 2026-08-31 | 2026-08-27 | Antz Christoph Rudiger | P | 5,000 | $1.53 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.